There are 2867 resources available
275TiP - ASCENT-03: Phase III study of sacituzumab govitecan (SG) vs treatment of physician’s choice (TPC) in first-line (1L) metastatic triple-negative breast cancer (mTNBC)
Presenter: Aditya Bardia
Session: Poster session 02
276TiP - ASCENT-04/KEYNOTE-D19: Phase III study of sacituzumab govitecan (SG) plus pembrolizumab (pembro) vs treatment of physician’s choice (TPC) plus pembro in first-line (1L) programmed death-ligand 1-positive (PD-L1+) metastatic triple-negative breast cancer (mTNBC)
Presenter: Sara Tolaney
Session: Poster session 02
290P - Potential enrichment strategies for next-generation sequencing (NGS) in primary brain cancers (pBCs) in a clinical series according to ESMO scale for clinical actionability of molecular targets (ESCAT)
Presenter: Oriol Mirallas
Session: Poster session 02
291P - Prognosis of glioblastoma according to different TERT promoter mutations
Presenter: Ainhoa Hernandez Gonzalez
Session: Poster session 02
292P - Androgen receptor signalling is associated with resistance to temozolomide and tumour growth in glioblastoma
Presenter: Cristina Birzu
Session: Poster session 02
293P - Molecular biomarkers correlation in symptomatic tumor-related epilepsy: A preliminary study on 151 cases of brain tumors
Presenter: Eugenia Cella
Session: Poster session 02
294P - Adult population with BRAF-mutated (BRAFmut) and NF1-mutated (NF1mut) gliomas. Analysis of the potential role of targeted therapy (TT) in these patients (pts)
Presenter: Maria Julia Lostes Bardaji
Session: Poster session 02
295P - PIK3CA in Asia: A landscape analysis of 1974 Chinese glioma samples
Presenter: ying Gao
Session: Poster session 02
296P - Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis
Presenter: Soon Khai Low
Session: Poster session 02
297P - The genetic profile of primary and recurrent gliomas: A mono-institutional experience using next-generation sequencing
Presenter: Marta Padovan
Session: Poster session 02